相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
Oliver Zolk et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
I. S. Song et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
Shu-Feng Zhou
CURRENT DRUG METABOLISM (2008)
Interaction of oral antidiabetic drugs with hepatic uptake transporters -: Focus on organic anion transporting polypeptides and organic cation transporter 1
Louri Bachmakov et al.
DIABETES (2008)
Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection
Norma Jung et al.
DRUG METABOLISM AND DISPOSITION (2008)
Caki-1 cells as a model system for the interaction of renally secreted drugs with OCT3
Natalie Glube et al.
NEPHRON PHYSIOLOGY (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
Zhi-Jun Wang et al.
PHARMACOGENETICS AND GENOMICS (2008)
Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1-3 in vitro and implications for drug-drug interactions
K. -I. Umehara et al.
XENOBIOTICA (2008)
Physiology, structure, and regulation of the cloned organic anion transporters
C. Srimaroeng et al.
XENOBIOTICA (2008)
Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans
Soichiro Matsushima et al.
DRUG METABOLISM AND DISPOSITION (2008)
Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats
Tomoji Maeda et al.
DRUG METABOLISM AND DISPOSITION (2007)
Bosentan is a substrate of human OATP1B1 and OATP1B3:: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin a, rifampicin, and sildenafil
Alexander Treiber et al.
DRUG METABOLISM AND DISPOSITION (2007)
Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3
Johannes Noe et al.
DRUG METABOLISM AND DISPOSITION (2007)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3
Annick Seithel et al.
DRUG METABOLISM AND DISPOSITION (2007)
Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H-2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates
K.-I. Umehara et al.
XENOBIOTICA (2007)
Organic anion transporters of the SLC22 family: Biopharmaceutical, physiological, and pathological roles
Ahsan N. Rizwan et al.
PHARMACEUTICAL RESEARCH (2007)
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Pertti J. Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin
Mikko Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain
Anne Amphoux et al.
NEUROPHARMACOLOGY (2006)
Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate
TM Polasek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacogenomics of human OATP transporters
J König et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
DA Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
DL Bourdet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans
M Shimizu et al.
DRUG METABOLISM AND DISPOSITION (2005)
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
E Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells
K Kopplow et al.
MOLECULAR PHARMACOLOGY (2005)
Effect of OATPIBI (SLCOIBI) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
JY Chung et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel
NF Smith et al.
CANCER BIOLOGY & THERAPY (2005)
Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium
KS Lips et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
Y Kameyama et al.
PHARMACOGENETICS AND GENOMICS (2005)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Hepatic uptake of the novel antifungal agent caspofungin
P Sandhu et al.
DRUG METABOLISM AND DISPOSITION (2005)
Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)
M Niemi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2
WM Suhre et al.
MOLECULAR PHARMACOLOGY (2005)
Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney
T Mikkaichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: Implications for understanding troglitazone hepatotoxicity
T Nozawa et al.
DRUG METABOLISM AND DISPOSITION (2004)
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins - Introduction
MA Hediger et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Organic anion transporting polypeptides of the OATP/SLC21 family:: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties
B Hagenbuch et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans
M Hirano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)
K Letschert et al.
PHARMACOGENETICS (2004)
HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2)
A Gupta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors
TA Jacobson
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin:: Analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil
Y Shitara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The effect of gemfibrozil on the pharmacokinetics of rosuvastatin
DW Schneck et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Functional variants of OCTN cation transporter genes are associated with Crohn disease
VD Peltekova et al.
NATURE GENETICS (2004)
Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes
K Ito et al.
DRUG METABOLISM AND DISPOSITION (2003)
Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes:: Consequences for pravastatin pharmacokinetics
Y Nishizato et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance
C Kyrklund et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin
O Briz et al.
BIOCHEMICAL JOURNAL (2003)
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1
D Bednarczyk et al.
MOLECULAR PHARMACOLOGY (2003)
Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A
Y Shitara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation
RG Tirona et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes
JS Wang et al.
DRUG METABOLISM AND DISPOSITION (2002)
Gemfibrozil greatly increases plasma concentrations of cerivastatin
JT Backman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2)
MJ Dresser et al.
PHARMACEUTICAL RESEARCH (2002)
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
SR Vavricka et al.
HEPATOLOGY (2002)
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3
M Hayer-Zillgen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole
PLM van Giersbergen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Glucuronidation of statins in animals and humans: A novel mechanism of statin lactonization
T Prueksaritanont et al.
DRUG METABOLISM AND DISPOSITION (2002)
Cerivastatin and gemfibrozil-associated rhabdomyolysis
J Bruno-Joyce et al.
ANNALS OF PHARMACOTHERAPY (2001)
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6
Y Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Organic anion-transporting potypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
GA Kullak-Ublick et al.
GASTROENTEROLOGY (2001)
Plasma concentrations of active simvastatin acid are increased by gemfibrozil
JT Backman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide
J König et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family
I Tamai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
